Intravenous granisetron — establishing the optimal dose
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28, S6-S11
- https://doi.org/10.1016/0959-8049(92)90629-g
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Are all 5-HT3 receptor antagonists the same?European Journal Of Cancer, 1992
- Predictive Factors of Delayed Emesis in Cisplatin-Treated Patients and Antiemetic Activity and Tolerability of Metoclopramide or DexamethasoneAmerican Journal of Clinical Oncology, 1991
- The concept of selectivity in 5-HT receptor researchEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1989
- Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.Journal of Clinical Oncology, 1985